BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 28943045)

  • 1. Prognostic factors for tube feeding dependence after curative (chemo-) radiation in head and neck cancer: A systematic review of literature.
    Wopken K; Bijl HP; Langendijk JA
    Radiother Oncol; 2018 Jan; 126(1):56-67. PubMed ID: 28943045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a multivariable normal tissue complication probability (NTCP) model for tube feeding dependence after curative radiotherapy/chemo-radiotherapy in head and neck cancer.
    Wopken K; Bijl HP; van der Schaaf A; van der Laan HP; Chouvalova O; Steenbakkers RJ; Doornaert P; Slotman BJ; Oosting SF; Christianen ME; van der Laan BF; Roodenburg JL; Leemans CR; Verdonck-de Leeuw IM; Langendijk JA
    Radiother Oncol; 2014 Oct; 113(1):95-101. PubMed ID: 25443500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age most significant predictor of requiring enteral feeding in head-and-neck cancer patients.
    Sachdev S; Refaat T; Bacchus ID; Sathiaseelan V; Mittal BB
    Radiat Oncol; 2015 Apr; 10():93. PubMed ID: 25896830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose to the inferior pharyngeal constrictor predicts prolonged gastrostomy tube dependence with concurrent intensity-modulated radiation therapy and chemotherapy for locally-advanced head and neck cancer.
    Vlacich G; Spratt DE; Diaz R; Phillips JG; Crass J; Li CI; Shyr Y; Cmelak AJ
    Radiother Oncol; 2014 Mar; 110(3):435-40. PubMed ID: 24440043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction model for tube feeding dependency during chemoradiotherapy for at least four weeks in head and neck cancer patients: A tool for prophylactic gastrostomy decision making.
    Willemsen ACH; Kok A; van Kuijk SMJ; Baijens LWJ; de Bree R; Devriese LA; Hoebers FJP; Lalisang RI; Schols AMWJ; Terhaard CHJ; Hoeben A
    Clin Nutr; 2020 Aug; 39(8):2600-2608. PubMed ID: 31839429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic versus reactive gastrostomy tube placement in advanced head and neck cancer treated with definitive chemoradiotherapy: A systematic review.
    McClelland S; Andrews JZ; Chaudhry H; Teckie S; Goenka A
    Oral Oncol; 2018 Dec; 87():77-81. PubMed ID: 30527247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of dosimetric factors on long-term percutaneous enteral gastrostomy (PEG) tube dependence in head and neck cancer patients after (chemo)radiotherapy-results from a prospective randomized trial.
    Löser A; Grohmann M; Finger A; Greinert F; Krause L; Molwitz I; Krüll A; Petersen C
    Strahlenther Onkol; 2022 Nov; 198(11):1016-1024. PubMed ID: 36006437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enteral feeding in head and neck cancer patients at a UK cancer centre.
    Sheth CH; Sharp S; Walters ER
    J Hum Nutr Diet; 2013 Oct; 26(5):421-8. PubMed ID: 23379517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of submandibular gland and swallowing structure sparing to post-radiation therapy PEG dependence in oropharynx cancer patients treated with split-neck IMRT technique.
    Gensheimer MF; Nyflot M; Laramore GE; Liao JJ; Parvathaneni U
    Radiat Oncol; 2016 Nov; 11(1):151. PubMed ID: 27846899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretreatment risk stratification of feeding tube use in patients treated with intensity-modulated radiotherapy for head and neck cancer.
    Anderson NJ; Jackson JE; Smith JG; Wada M; Schneider M; Poulsen M; Rolfo M; Fahandej M; Gan H; Joon DL; Khoo V
    Head Neck; 2018 Oct; 40(10):2181-2192. PubMed ID: 29756389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive Factors for Prophylactic Percutaneous Endoscopic Gastrostomy (PEG) Tube Placement and Use in Head and Neck Patients Following Intensity-Modulated Radiation Therapy (IMRT) Treatment: Concordance, Discrepancies, and the Role of Gabapentin.
    Yang W; McNutt TR; Dudley SA; Kumar R; Starmer HM; Gourin CG; Moore JA; Evans K; Allen M; Agrawal N; Richmon JD; Chung CH; Quon H
    Dysphagia; 2016 Apr; 31(2):206-13. PubMed ID: 26753929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From reactive to proactive tube feeding during chemoradiotherapy for head and neck cancer: A clinical prediction model-based approach.
    Karsten RT; Stuiver MM; van der Molen L; Navran A; de Boer JP; Hilgers FJM; Klop WMC; Smeele LE
    Oral Oncol; 2019 Jan; 88():172-179. PubMed ID: 30616790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute toxicity in comprehensive head and neck radiation for nasopharynx and paranasal sinus cancers: cohort comparison of 3D conformal proton therapy and intensity modulated radiation therapy.
    McDonald MW; Liu Y; Moore MG; Johnstone PA
    Radiat Oncol; 2016 Feb; 11():32. PubMed ID: 26922239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Nutritional and Clinical Outcomes in Patients with Head and Neck Cancer Undergoing Chemoradiotherapy Utilizing Prophylactic versus Reactive Nutrition Support Approaches.
    Brown TE; Banks MD; Hughes BGM; Lin CY; Kenny LM; Bauer JD
    J Acad Nutr Diet; 2018 Apr; 118(4):627-636. PubMed ID: 27986517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of a prediction model for tube feeding dependence after curative (chemo-) radiation in head and neck cancer.
    Wopken K; Bijl HP; van der Schaaf A; Christianen ME; Chouvalova O; Oosting SF; van der Laan BF; Roodenburg JL; Leemans CR; Slotman BJ; Doornaert P; Steenbakkers RJ; Verdonck-de Leeuw IM; Langendijk JA
    PLoS One; 2014; 9(4):e94879. PubMed ID: 24736318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and external validation of a prediction model for tube feeding dependency for at least four weeks during chemoradiotherapy for head and neck cancer.
    Willemsen ACH; Kok A; Baijens LWJ; de Boer JP; de Bree R; Devriese LA; Driessen CML; van Herpen CML; Hoebers FJP; Kaanders JHAM; Karsten RT; van Kuijk SMJ; Lalisang RI; Navran A; Pereboom SR; Schols AMWJ; Terhaard CHJ; Hoeben A
    Clin Nutr; 2022 Jan; 41(1):177-185. PubMed ID: 34883306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical-dosimetric analysis of measures of dysphagia including gastrostomy-tube dependence among head and neck cancer patients treated definitively by intensity-modulated radiotherapy with concurrent chemotherapy.
    Li B; Li D; Lau DH; Farwell DG; Luu Q; Rocke DM; Newman K; Courquin J; Purdy JA; Chen AM
    Radiat Oncol; 2009 Nov; 4():52. PubMed ID: 19909531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. External validation of a multifactorial normal tissue complication probability model for tube feeding dependence at 6 months after definitive radiotherapy for head and neck cancer.
    Kanayama N; Kierkels RGJ; van der Schaaf A; Steenbakkers RJHM; Yoshioka Y; Nishiyama K; Fujii T; Ogawa K; Langendijk JA; Teshima T
    Radiother Oncol; 2018 Nov; 129(2):403-408. PubMed ID: 30301559
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Jackson JE; Anderson NJ; Rolfo M; Wada M; Schneider M; Poulsen M; Fahandej M; Huynh A; Lee ST; Joon DL; Khoo V
    Dysphagia; 2019 Jun; 34(3):341-349. PubMed ID: 30267142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced feeding tube duration with intensity-modulated radiation therapy for head and neck cancer: A Surveillance, Epidemiology, and End Results-Medicare Analysis.
    Beadle BM; Liao KP; Giordano SH; Garden AS; Hutcheson KA; Lai SY; Guadagnolo BA
    Cancer; 2017 Jan; 123(2):283-293. PubMed ID: 27662641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.